KRW
EXAS

Kaufman Rossin Wealth’s Exact Sciences EXAS Stock Holding History

Kaufman Rossin Wealth’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,693
Closed -$274K – 130
2025
Q4 		$274K Buy
+2,693
New +$216K 0.14% 118

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Kaufman Rossin Wealth's EXAS Position: Q1 2026 in Review

Kaufman Rossin Wealth sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,693 shares — an estimated $274K sold.

Kaufman Rossin Wealth first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $274K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Kaufman Rossin Wealth reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Kaufman Rossin Wealth sold 2,693 Exact Sciences shares in Q1 2026, an estimated $274K.
  • Kaufman Rossin Wealth first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
  • Kaufman Rossin Wealth's Exact Sciences position peaked at $274K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Kaufman Rossin Wealth's 13F filing for Q1 2026, filed 17 Apr 2026.